Your browser doesn't support javascript.
loading
Mathematical Modeling: A Tool for Optimization of Lipid Nanoparticle-Mediated Delivery of siRNA.
Mihaila, Radu; Ruhela, Dipali; Keough, Edward; Cherkaev, Elena; Chang, Silvia; Galinski, Beverly; Bartz, René; Brown, Duncan; Howell, Bonnie; Cunningham, James J.
Afiliação
  • Mihaila R; Sirna Therapeutics, 1700 Owens Street, Fourth Floor, San Francisco, CA 94158, USA. Electronic address: mihailar@gene.com.
  • Ruhela D; Sirna Therapeutics, 1700 Owens Street, Fourth Floor, San Francisco, CA 94158, USA.
  • Keough E; Department of RNA Therapeutics, Merck Sharp & Dohme Corp., West Point, PA 19486, USA.
  • Cherkaev E; Department of Mathematics, University of Utah, Salt Lake City, UT 84112, USA.
  • Chang S; Sirna Therapeutics, 1700 Owens Street, Fourth Floor, San Francisco, CA 94158, USA.
  • Galinski B; Sirna Therapeutics, 1700 Owens Street, Fourth Floor, San Francisco, CA 94158, USA.
  • Bartz R; Department of RNA Therapeutics, Merck Sharp & Dohme Corp., West Point, PA 19486, USA.
  • Brown D; Sirna Therapeutics, 1700 Owens Street, Fourth Floor, San Francisco, CA 94158, USA.
  • Howell B; Department of RNA Therapeutics, Merck Sharp & Dohme Corp., West Point, PA 19486, USA.
  • Cunningham JJ; Department of RNA Therapeutics, Merck Sharp & Dohme Corp., West Point, PA 19486, USA.
Mol Ther Nucleic Acids ; 7: 246-255, 2017 Jun 16.
Article em En | MEDLINE | ID: mdl-28624200
ABSTRACT
Lipid nanoparticles (LNPs) have been used to successfully deliver small interfering RNAs (siRNAs) to target cells in both preclinical and clinical studies and currently are the leading systems for in vivo delivery. Here, we propose the use of an ordinary differential equation (ODE)-based model as a tool for optimizing LNP-mediated delivery of siRNAs. As a first step, we have used a combination of experimental and computational approaches to develop and validate a mathematical model that captures the critical features for efficient siRNA-LNP delivery in vitro. This model accurately predicts mRNA knockdown resulting from novel combinations of siRNAs and LNPs in vitro. As demonstrated, this model can be effectively used as a screening tool to select the most efficacious LNPs, which can then further be evaluated in vivo. The model serves as a starting point for the future development of next generation models capable of capturing the additional complexity of in vivo delivery.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2017 Tipo de documento: Article